An equally memorable call was made about the same time by Flynn of Lazard with the target price of 13. My record shows that the traders faithfully followed the 'order' to bring the share price down below 14 on March 11 of 2008. They are the two great calls of 2008 together with Ding squared's call. I am sure many long term investors gave up their shares near the 4 year bottom, and they would have been heartsick if they didn't buy back. Analysts should be very careful in making 'sell' and 'strong sell' calls. Because there are so many unknown factors in drug developments, and analysts' calls are well respected, they should be very very careful in making extreme calls.